Filters

Anti-HBsAg (Polyclonal), ALEXA Fluor 594

Anti-HBsAg (Polyclonal), ALEXA Fluor 594 size: 100 microliters 489

Supplier BIOSS POLYCLONAL ANTIBODIES
Price 489
Size 100 microliters
Contact us Ask Component cell markers and DNA bp. markers are genetic markerser genes or DNA sequenceswith selection audit
TypeConjugated Primary Antibody
Conjugated with 594, ALEXA FLUOR®
Host organismGoat (Capra aegagrus hircus)
Target Protein/PeptideHBsAg
SpecificityThis antibody reacts specifically with HBsAg
ModificationNo modification has been applied to this antibody
Modification siteNone
ClonalityPolyclonal Antibody
ClonePolyclonal Antibodies
Concentration1ug per 1ul
Subcellular locationsN/A
Antigen SourceHuman Hepatitis B Surface Antigen
Gene ID4134
Swiss ProtP27816
ApplicationsIF(IHC-P)
Applications with corresponding dilutionsIF(IHC-P)(1:50-200)
Cross reactive speciesHuman (Homo sapiens)
Cross Reactive Species details However, note that due to limited knowledge it is impossible to predict with 100% guarantee that the antibody does not corss react with any other species, No significant cross reactivity has been observed for this antibody for the tested species
Background information HBV belongs to the Hepadnaviridae family of viruses, HBsAg has antigenic heterogeneity, Hepatitis B infection is normally diagnosed from serological tests that detect HBsAg but as the disease progresses this antigen may no longer be present in the blood and tests for HBcAg are used, If HBsAg can be detected in the blood for longer than six months, Infection also increases the risk of hepatocellular carcinoma, Its genome consists of partially double stranded circular DNA, The DNA is enclosed in a nucleocapsid, The HBV genome also encodes a DNA polymerase that also acts as a reverse transcriptase, The antigenic determinant of the protein moiety of the HBsAg determines specific characteristics of different serotypes and provides the basis of immunodetection, The core antigen shares its sequences with the e antigen (HBeAg) but no cross reactivity between the two proteins has been observed, adr, ayr, ayw, chronic hepatitis B is diagnosed, d/y and w/r allow the following combinations: adw, inflammation and viral persistence, or core antigen (HBcAg), specifically, two pairs of sub specific determinants, which is surrounded by a spherical envelope (surface antigen or HBsAg), Hepatitis B Virus (HBV) infection induces a disease state characterised by liver damage
Purification methodPurified by Protein A
Storage 50% glycerol and 0, Store at 4°, 09% sodium azide, C for 12 months, Water buffered solution containing 100ug/ml BSA
Excitation emission590nm/617nm
Synonyms MAP-4, MAP4, Microtubule-associated protein 4
Also known asHBsAg Polyclonal Antibody
Other nameAnti-HBsAg Polyclonal
Advisory For antibodies that are in liquid form or reconstituted lyophilized antibodies small amounts could become entrapped on the seal or the walls of the tube, Prior to use briefly centrifuge the vial to gather all the solution on the bottom, specificity and sensitivity, thus reducing its reactivity, Avoid freeze/thaw cycles as they may denaturate the polypeptide chains of the antibody
PropertiesFor facs or microscopy Alexa 1 conjugate
ConjugationAlexa Fluor
GroupPolyclonals and antibodies
About The advantage is that there are more epitopes available in a polyclonal antiserum to detect the proteins than in monoclonal sera, immunohistochemistry on frozen slices or parrafin fixed tissues, Polyclonals can be used for Western blot
Gene targetHBsAg
Short nameAnti-HBsAg (Polyclonal) Fluor 594
Technique Pabs are a collection of immunoglobulin , Polyclonal antibodies , each identifying a different , whereas , (pAbs) are mostly rabbit or goat , B cells, Polyclonal, antibodies , antigen, come from a single N cell lineage, epitope, molecules that react against a specific , monoclonal antibodies , that are secreted by different 
LabelALEXA
Alternative name ALEXA Fluor 594, antibody to-Hepatitis B surface antigen (polyclonal)
Alternative techniquepolyclonals

Similar products

Subscribe to our Newsletter